How We Do It®: New Combinations Reshaping Treatment Decision-Making in Newly Diagnosed Multiple Myeloma
This program is supported by Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, both are Johnson & Johnson companies, and Sanofi.
7:00 p.m. - 10:00 p.m. Pacific time
ACCESS PROGRAM HERE
San Diego Convention Center
Room 30
On Demand program will be available here December 7, 2024.
Access Program Here
The live portion of this activity will be presented as a 2.0-hour Friday Satellite Symposium (FSS). The activity is designed to highlight and test participants on the most clinically relevant data in NDMM, provide expert guidance on the interpretation of core concepts, and forecast the clinical impact of recent data sets. The activity will integrate a series of How We Do It® panel discussions alongside didactic presentations. To further enhance the integration of recent data into practice, the program will feature an interactive question-and-answer session with faculty throughout the activity to emphasize areas of educational need, highlighting areas of debate, and illustrating the application of new data in defined clinical situations. To further enhance the integration of recent data into practice, the program will feature an interactive question-and-answer session between the faculty and attendees to emphasize areas of educational need, highlight areas of debate, and illustrate the application of new data in defined clinical situations.
Chair:
Ola Landgren
University of Miami
Miami, FL
Speakers:
Cristina Gasparetto, MD
Duke University Medical Center
Durham, NC
Katja C. Weisel, MD
Department of Oncology, Hematology and BMT, University Medical Center of Hamburg-Eppendorf
Hamburg, Germany
Elijah Anseaume
, Physicians' Education Resource
Email: eanseaume@gotoper.com